← All trials
NCT05042024
Phase 3Interventional
Includes trials conducted after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather additional information to evaluate the overall benefit-risk relationship of the drug.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Oct 20, 2017
- Primary completion
- Oct 2, 2018
- Completion date
- Nov 1, 2018
- First posted
- Sep 13, 2021
- Last posted
- Sep 17, 2021
- Enrollment
- 75
- Arms / groups
- 3 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Ukrainian Medical Stomatological AcademyLead sponsor
- Ukrainian Medical Stomatological AcademyReponsible party - principal investigator
- Ukrainian Medical Stomatological AcademyOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.